HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act

Area of Science:

• Immunogenetics
• Transplantation immunology

Background:

• Human Leukocyte Antigen (HLA) matching in organ transplantation improves graft function, survival, and reduces rejection episodes.
• HLA mismatches increase rejection risk, necessitate higher immunosuppression, and raise concerns for infection, malignancy, and sensitization.
• Factors beyond HLA, like donor age and type, influence transplant success, complicating donor selection.

Approach:

• Evaluating the immunologic barrier posed by different HLA mismatches based on patient HLA phenotype.
• Assessing the impact of repeated mismatches and pre-existing patient HLA antibodies (sensitization).
• Defining optimal donor HLA types and their occurrence probability to guide donor selection.

Key Points:

• Strategies must identify least immunogenic mismatches and consider patient sensitization.
• Donor selection involves balancing waiting time for an ideal match versus accepting a suboptimal donor.
• Expanding donor pools via paired donation or desensitization may be necessary when optimal donors are unavailable.

Conclusions:

• Transplantation decisions require a careful balance between the risks of waiting and the risks of using a less-than-ideal donor.
• Personalized strategies considering immunologic factors are crucial for optimizing organ transplant outcomes.
• Addressing immunologic barriers can improve transplant success rates for a broader patient population.